Medicinálny Kyslík Plynný Sol (Oxygen)

Inhaled oxygen diffuses across the alveolar membrane into the bloodstream, increasing the partial pressure of O₂ in the blood. This elevates the amount of oxygen bound to hemoglobin and dissolved in plasma, allowing more oxygen to reach tissues and support cellular metabolism.

The prescribed dose of Medicinálny Kyslík Plynný Sol is determined by the treating clinician based on the patient’s oxygen saturation, underlying condition, and clinical response. The prescriber sets the flow rate and duration appropriate for each individual case.

Safety data for Medicinálny Kyslík Plynný Sol in pregnancy and lactation are limited. Oxygen therapy is generally considered when the benefits outweigh potential risks, and it should be used under medical supervision. Pregnant or nursing patients should discuss use with their healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and import documentation.

Medicinálny Kyslík Plynný Sol is a high‑purity medical gas supplied in cylinders, offering reliable, on‑demand oxygen. Compared with liquid oxygen systems or concentrators, cylinder‑based oxygen provides consistent concentration and can be used in settings without electricity, though it requires careful handling and storage.

Store the oxygen cylinders at ambient temperature, upright, in a well‑ventilated area away from heat sources, open flames or combustible materials. Protect cylinders from physical damage and ensure valve protection caps are in place when not in use.

The gas is delivered via a regulator attached to a cylinder and connected to a delivery device such as a nasal cannula, simple face mask, or non‑rebreather mask. The prescriber sets the flow rate (e.g., liters per minute) according to the patient’s oxygen needs.

Serious risks include fire or explosion in high‑oxygen environments, pulmonary oxygen toxicity from prolonged high concentrations, and worsening hypercapnia in patients with chronic obstructive pulmonary disease who rely on hypoxic drive for breathing.

Patients with untreated pneumothorax, those who are hypersensitive to oxygen, or individuals for whom high‑flow oxygen could exacerbate CO₂ retention (e.g., certain COPD patients) should avoid its use unless closely monitored by a qualified clinician.